Pharos iBio Co., Ltd. (KOSDAQ: 388870)
South Korea
· Delayed Price · Currency is KRW 7,440.00
-360.00 (-4.62%)
Dec 20, 2024, 9:00 AM KST
Pharos iBio Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Operating Revenue | - | - | 300 | 57 | 187.68 | 421.11 |
| Other Revenue | - | - | - | -0 | - | -0 |
| Revenue | - | - | 300 | 57 | 187.68 | 421.11 |
| Revenue Growth (YoY) | - | - | 426.32% | -69.63% | -55.43% | - |
| Cost of Revenue | 25.08 | 11.02 | 192.49 | 52.09 | 213.76 | 183.93 |
| Gross Profit | -25.08 | -11.02 | 107.52 | 4.91 | -26.08 | 237.18 |
| Selling, General & Admin | 3,129 | 3,226 | 2,988 | 2,459 | 1,481 | 1,258 |
| Research & Development | 8,192 | 6,138 | 7,085 | 5,544 | 4,340 | 1,587 |
| Other Operating Expenses | 10.77 | 56.29 | 75.93 | 57.34 | 44.09 | 24.6 |
| Operating Expenses | 12,116 | 10,106 | 10,727 | 8,411 | 6,021 | 2,986 |
| Operating Income | -12,141 | -10,117 | -10,619 | -8,406 | -6,047 | -2,749 |
| Interest Expense | -7.4 | -11.24 | -3,222 | -6,513 | -4,278 | -1,571 |
| Interest & Investment Income | 859.59 | 690.24 | 320.48 | 116.43 | 105.06 | 91.55 |
| Currency Exchange Gain (Loss) | 56.02 | 28.37 | 346.05 | 205.32 | -180.24 | -0.05 |
| Other Non Operating Income (Expenses) | 557.42 | 592.65 | -3,911 | -16,877 | -2,971 | -741.27 |
| EBT Excluding Unusual Items | -10,676 | -8,817 | -17,086 | -31,474 | -13,371 | -4,969 |
| Gain (Loss) on Sale of Investments | - | - | - | - | -27.15 | 17.83 |
| Gain (Loss) on Sale of Assets | -37.27 | -41.7 | 24.43 | 3.2 | - | - |
| Pretax Income | -10,713 | -8,858 | -17,062 | -31,471 | -13,398 | -4,951 |
| Net Income | -10,713 | -8,858 | -17,062 | -31,471 | -13,398 | -4,951 |
| Net Income to Common | -10,713 | -8,858 | -17,062 | -31,471 | -13,398 | -4,951 |
| Shares Outstanding (Basic) | 13 | 12 | 9 | 6 | 6 | 6 |
| Shares Outstanding (Diluted) | 13 | 12 | 9 | 6 | 6 | 6 |
| Shares Change (YoY) | 10.01% | 36.26% | 53.03% | 2.65% | 1.86% | - |
| EPS (Basic) | -829.10 | -732.03 | -1921.10 | -5422.59 | -2369.66 | -892.00 |
| EPS (Diluted) | -829.26 | -732.03 | -1921.10 | -5422.59 | -2369.66 | -892.00 |
| Free Cash Flow | -9,068 | -8,253 | -8,512 | -8,489 | -5,551 | -2,361 |
| Free Cash Flow Per Share | -701.82 | -681.98 | -958.45 | -1462.70 | -981.82 | -425.26 |
| Gross Margin | - | - | 35.84% | 8.61% | -13.90% | 56.32% |
| Operating Margin | - | - | -3539.83% | -14747.27% | -3221.87% | -652.76% |
| Profit Margin | - | - | -5687.23% | -55211.96% | -7138.82% | -1175.82% |
| Free Cash Flow Margin | - | - | -2837.42% | -14892.94% | -2957.82% | -560.57% |
| EBITDA | -11,357 | -9,432 | -10,041 | -8,056 | -5,891 | -2,632 |
| D&A For EBITDA | 784.54 | 684.91 | 578.1 | 350.09 | 155.37 | 116.86 |
| EBIT | -12,141 | -10,117 | -10,619 | -8,406 | -6,047 | -2,749 |
| Advertising Expenses | - | - | - | 0.2 | 0.08 | 3 |
Source: S&P Capital IQ. Standard template. Financial Sources.